[1]
2017. ANTITUMOR EFFECT OF SUNITINIB AND BORTEZOMIB ON BREAST CANCER CELL LINE IN VITRO. Voprosy onkologii. 63, 1 (Jan. 2017), 141–145. DOI:https://doi.org/10.37469/0507-3758-2017-63-1-141-145.